- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- May 2025
- 389 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 186 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 191 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 380 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 152 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 376 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 72 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 282 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 216 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 148 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 196 Pages
Global
From €5341EUR$5,850USD£4,533GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more